CAPLIN POINT LAB LTD. Financial Ratios
CAPLIPOINT · Healthcare · Current price ₹2,696.8
P/E ratio
32.0x
P/B ratio
5.4x
ROE
20.6%
ROCE
25.0%
Debt / Equity
0.00
Dividend yield
0.3%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 32.0x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 5.4x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 20.6% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 25.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.00 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with CAPLIN POINT LAB LTD.'s latest numbers.
CAPLIN POINT LAB LTD. profitability
CAPLIN POINT LAB LTD. generates a return on equity of 20.6% and a return on capital employed of 25.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.00 and a P/E of 32.0x, CAPLIN POINT LAB LTD. is conservatively financed. Our overall business-quality score for the company is 6.1 / 10.
Understand the ratios
More on CAPLIN POINT LAB LTD.
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.